demonstrated that the MAPK1/3 kinase is involved in the proteasomal degradation of ULK1 via ubiquitination, mediated by the E3 ligase BTRC, contributing to the deregulation of ULK1 in breast cancer. The gene discussed is ULK1; the disease is breast carcinoma.